Related Experiment Video
Updated: May 19, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
A probable clinically significant interaction between warfarin and cloxacillin: three case reports
Hossein Khalili1, Naemeh Nikvarz, Farhad Najmeddin
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, PO Box 14155/6451, Tehran 1417614411, Iran. khalilih@tums.ac.ir
Cases:
Three patients were admitted to the Imam Hospital, Tehran, Iran with a diagnosis of bacterial endocarditis. The patients had indications for valve replacement surgery and anticoagulant therapy. The administration of cloxacillin reduced the effect of warfarin, and subsequent increases in warfarin doses were unable to overcome this effect.
Conclusion:
A decrease in warfarin anticoagulation effects was detected in our three patients following cloxacillin therapy for infective endocarditis. Penicillinase-resistant penicillins remain essential antibiotics in the treatment of severe infections caused by Staphylococcus aureus due to their bactericidal activity, safety, and cost. Thus, in situations where anticoagulants are indicated in patients with infective endocarditis, it would be better to replace warfarin with low-molecular-weight or unfractionated heparin.
Insights
Cloxacillin therapy for infective endocarditis can reduce warfarin
Area of Science:
- Infectious Diseases
- Pharmacology
- Cardiology
Background:
- Bacterial endocarditis requires effective antibiotic treatment.
- Anticoagulant therapy, often with warfarin, is crucial for patients with valvular heart disease or prosthetic valves.
- Managing concurrent infections and anticoagulation presents clinical challenges.
Observation:
- Three patients with bacterial endocarditis requiring valve replacement and anticoagulation received cloxacillin.
- Cloxacillin administration led to a significant reduction in warfarin's anticoagulation effect.
- Increased warfarin doses were insufficient to counteract the diminished anticoagulation.
Findings:
- Penicillinase-resistant penicillins, like cloxacillin, are vital for treating Staphylococcus aureus infections.
- A clinically significant drug interaction exists between cloxacillin and warfarin.
- Warfarin anticoagulation efficacy is compromised during cloxacillin treatment for endocarditis.
Implications:
- Clinicians should monitor anticoagulation closely in patients receiving cloxacillin and warfarin concurrently.
- Alternative anticoagulants, such as low-molecular-weight heparin or unfractionated heparin, may be preferable in patients with infective endocarditis requiring anticoagulation.
- This interaction highlights the importance of considering antibiotic-anticoagulant pharmacodynamics in complex patient management.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

